Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mauricio Fernando Ribeiro"'
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Intimal sarcoma (InS) is an ultra-rare and aggressive subtype of soft tissue sarcoma (STS). It usually arises in large mediastinal arteries and the heart. In the advanced setting, sequential cytotoxic chemotherapy is often used, mainly based on retro
Externí odkaz:
https://doaj.org/article/2e77d55b658144cd8f1e55c3753f6141
Autor:
Mauricio Fernando Ribeiro, Hagit Peretz Soroka, Zainab Bhura, Ian Hirsch, Jay Wunder, Peter Ferguson, Kim Tsoi, Savtaj Brar, Rebecca Gladdy, Carol Swallow, Peter Chung, Charles Catton, Philip Wong, Geoffrey Watson, Albiruni Ryan Abdul Razak, Abha A. Gupta, David Shultz
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Radiation-induced sarcomas (RIS) tend to have aggressive behaviour and because of their rarity, the most appropriate management for these malignancies is uncertain. Objectives: Using the Canadian Sarcoma Research and Clinical Collaboratio
Externí odkaz:
https://doaj.org/article/f74bf08d908341dd90018106da6602e9
Autor:
Seth Kibel, Nathan Kuehne, Mauricio Fernando Ribeiro, Thiago P. Muniz, Xiang Y. Ye, Anna Spreafico, Samuel D. Saibil, Alexander Sun, David Y. Mak, Diana Gray, Bailie Jones, Philip Wong, Marcus O. Butler
Publikováno v:
Cancers, Vol 15, Iss 24, p 5867 (2023)
Modern adjuvant systemic therapies (STs) have revolutionized the management of stage III melanoma. Currently, the role of adjuvant radiotherapy (RT) remains unclear. In this single-center retrospective study, patients with clinically detectable stage
Externí odkaz:
https://doaj.org/article/7f20f20543444df5942ddb0eef2f3a58
Autor:
Erica C. Koch Hein, Maysa Vilbert, Ian Hirsch, Mauricio Fernando Ribeiro, Thiago P. Muniz, Cynthia Fournier, Khaled Abdulalem, Erick F. Saldanha, Erika Martinez, Anna Spreafico, David H. Hogg, Marcus O. Butler, Samuel D. Saibil
Publikováno v:
Cancers, Vol 15, Iss 17, p 4312 (2023)
Immune checkpoint inhibitors (ICI) cemiplimab and pembrolizumab have revolutionized the treatment of advanced cutaneous squamous cell carcinoma (cSCC). We aimed to evaluate the effectiveness and safety of ICI in a real-world cSCC population, includin
Externí odkaz:
https://doaj.org/article/c51c397835ed4012a1296160fefba4e6
Autor:
Marcello Moro Queiroz, Karina Perez Sacardo, Mauricio Fernando Ribeiro, Luiza Lara Gadotti, Rodrigo Saddi, Leandro Jonata de Carvalho Oliveira, Rudinei Diogo Marques Linck, Marcelo Rocha de Souza Cruz, Romualdo Barroso-Sousa, Marina Sahade, Tatiana Strava Correa, Max Senna Mano, Daniele Assad Suzuki, Andrea Kazumi Shimada, Artur Katz
Publikováno v:
Cancer Treatment and Research Communications, Vol 35, Iss , Pp 100683- (2023)
Background: Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) have been recently developed and introduced into clinical practice. Methods: We retrospectively analyzed data from patients with confirmed HR+/HER2 metastatic breast cancer treated with hor
Externí odkaz:
https://doaj.org/article/f00841e7cf3c4c4fa3e29cdc2d34613b